ATE472102T1 - Verfahren zur vorhersage von anomalien des lipidmetabolismus - Google Patents
Verfahren zur vorhersage von anomalien des lipidmetabolismusInfo
- Publication number
- ATE472102T1 ATE472102T1 AT04808108T AT04808108T ATE472102T1 AT E472102 T1 ATE472102 T1 AT E472102T1 AT 04808108 T AT04808108 T AT 04808108T AT 04808108 T AT04808108 T AT 04808108T AT E472102 T1 ATE472102 T1 AT E472102T1
- Authority
- AT
- Austria
- Prior art keywords
- compound
- predicting
- lipidosis
- abnomals
- lipid metabolism
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003434151 | 2003-12-26 | ||
JP2004168849 | 2004-06-07 | ||
PCT/JP2004/019758 WO2005064344A1 (ja) | 2003-12-26 | 2004-12-24 | 脂質代謝異常症の予測方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE472102T1 true ATE472102T1 (de) | 2010-07-15 |
Family
ID=34742146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04808108T ATE472102T1 (de) | 2003-12-26 | 2004-12-24 | Verfahren zur vorhersage von anomalien des lipidmetabolismus |
Country Status (6)
Country | Link |
---|---|
US (1) | US7399638B2 (de) |
EP (1) | EP1710585B1 (de) |
JP (1) | JP4555779B2 (de) |
AT (1) | ATE472102T1 (de) |
DE (1) | DE602004027839D1 (de) |
WO (1) | WO2005064344A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080153928A1 (en) * | 2005-07-25 | 2008-06-26 | Basf Aktiengesellschaft | Method for Providing and Analyzing an Animal Population Having an Essentially Identical Metabolome |
JP5005955B2 (ja) * | 2006-05-24 | 2012-08-22 | 田辺三菱製薬株式会社 | 被験物質の脂質代謝異常症誘発可能性を予測する方法 |
US20110162437A1 (en) * | 2006-10-09 | 2011-07-07 | Lucette Doessegger | Biomarker for Mitochondrial Toxicity Associated with Phospholipidosis |
FI119745B (fi) * | 2006-12-05 | 2009-02-27 | Paavo Kinnunen | Menetelmä aineen fosfolipidoosia aiheuttavien ominaisuuksien ennustamiseksi |
WO2009026153A1 (en) * | 2007-08-17 | 2009-02-26 | Metabolon, Inc. | Biomarkers for alzheimer's disease and methods using the same |
JP5051617B2 (ja) * | 2007-12-17 | 2012-10-17 | 富士電機株式会社 | 遠心分離方法及び遠心分離装置 |
US8313949B2 (en) * | 2009-04-16 | 2012-11-20 | Nextcea Inc. | Detecting phospholipidosis and diagnosing lysosomal storage disorders |
US9459267B2 (en) * | 2014-05-12 | 2016-10-04 | Quest Diagnostics Investments Incorporated | Quantitation of tamoxifen and metabolites thereof by mass spectrometry |
JP6051257B2 (ja) * | 2015-04-15 | 2016-12-27 | ライオン株式会社 | 脂質異常症への罹患しやすさを試験する方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5100807A (en) | 1987-10-19 | 1992-03-31 | Abbott Laboratories | Phenylacetylglutamine (pag) analytical test |
JPH07104351B2 (ja) | 1988-09-29 | 1995-11-13 | 株式会社日本抗体研究所 | 脂質代謝異常検出用キット |
JPH11343300A (ja) | 1998-03-13 | 1999-12-14 | Tetsuro Fujita | 新規ハプテン、それを認識する抗体およびそれらを用いた免疫学的測定法 |
DE69940479D1 (de) | 1998-12-22 | 2009-04-09 | Daiichi Pure Chemicals Co Ltd | Monoklonaler antikörper gegen apolipoprotein a-i |
US6306603B1 (en) | 1999-01-08 | 2001-10-23 | Wakunaga Phaemaceutical Co., Ltd. | CD36 mutant gene and methods for diagnosing diseases caused by abnormal lipid metabolism and diagnostic kits therefor |
JP2001149082A (ja) | 1999-01-08 | 2001-06-05 | Wakunaga Pharmaceut Co Ltd | Cd36変異遺伝子並びに脂質代謝異常により引き起こされる疾患の判定法および診断キット |
JP2001066314A (ja) | 1999-06-23 | 2001-03-16 | E Miller Norman | 脂質代謝異常の検出方法及びこれを用いる疾病の検出方法 |
-
2004
- 2004-12-24 JP JP2005516727A patent/JP4555779B2/ja not_active Expired - Fee Related
- 2004-12-24 AT AT04808108T patent/ATE472102T1/de not_active IP Right Cessation
- 2004-12-24 US US10/584,366 patent/US7399638B2/en not_active Expired - Fee Related
- 2004-12-24 EP EP04808108A patent/EP1710585B1/de not_active Not-in-force
- 2004-12-24 WO PCT/JP2004/019758 patent/WO2005064344A1/ja not_active Application Discontinuation
- 2004-12-24 DE DE602004027839T patent/DE602004027839D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
US7399638B2 (en) | 2008-07-15 |
EP1710585A4 (de) | 2008-02-20 |
JP4555779B2 (ja) | 2010-10-06 |
US20070166829A1 (en) | 2007-07-19 |
WO2005064344A1 (ja) | 2005-07-14 |
EP1710585B1 (de) | 2010-06-23 |
EP1710585A1 (de) | 2006-10-11 |
JPWO2005064344A1 (ja) | 2007-07-19 |
DE602004027839D1 (de) | 2010-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tomat et al. | Imaging mobile zinc in biology | |
McClatchy et al. | 15N metabolic labeling of mammalian tissue with slow protein turnover | |
Scanu et al. | Evaluation of the use of human mesenchymal stem cells for acute toxicity tests | |
Wang et al. | Gut microbiota and relevant metabolites analysis in alcohol dependent mice | |
MA29282B1 (fr) | Procede de diagnostic d'une steatose hepatique au moyen de marqueurs biochimiques | |
RU2011129747A (ru) | Способы, относящиеся к модифицированным гликанам | |
Gailus-Durner* et al. | Systemic first-line phenotyping | |
GB0510943D0 (en) | Improved immunoassay methods | |
ATE472102T1 (de) | Verfahren zur vorhersage von anomalien des lipidmetabolismus | |
WO2002093129A3 (en) | Methods for analyzing interactions between proteins in live and intact cells | |
Emson et al. | A pilot study demonstrating a non-invasive method for the measurement of protein turnover in skin disorders: application to psoriasis | |
DE60217351D1 (de) | Verfahren zur identifizierung von proben eines säugetiers als auch ein kit zur durchführung des verfahrens | |
KR101872155B1 (ko) | 시스테인 검출용 이광자 형광 프로브 화합물 | |
Ruiz-Hernández et al. | Trace element and lipidomic analysis of bottlenose dolphin blubber from the Yucatan coast: Lipid composition relationships | |
Chiaradia et al. | In slow pace towards the proteome of equine body fluids | |
DE60317070D1 (de) | Verfahren zur diagnose von multipler sklerose | |
EP1043587A4 (de) | Verfahren zur untersuchung von nierenkrankheiten | |
CN110372738A (zh) | 一种定位脂滴检测硫化氢的荧光探针及其制备方法和应用 | |
Zee et al. | Quantitative imaging approaches to understanding biological processing of metal ions | |
DE60133997D1 (de) | Verfahren zum vorhersagen von preeclampsia und anderen krankheiten | |
WO2012165926A3 (ko) | 항-atic 자가면역항체를 포함하는 간암 진단 마커 및 이의 항원을 포함하는 간암 진단용 조성물 | |
BR0111975A (pt) | Fator, composição, veìculo, ligando, kits de diagnósticos, processos para detectar uma prpsc em uma amostra, e para remover prpsc de material biológico, método para diagnosticar encefalopatias espongiformes humanas transmissìveis e encefalopatias de prìons de animais, e, uso de um fator | |
JP6017724B1 (ja) | 十二指腸液試料の膵液由来成分検出用試料としての適性評価方法 | |
JP2018145111A (ja) | 生体分子検出用蛍光物質 | |
Zangarelli et al. | Centrifugation-based isolation of myosin for measurement of its synthesis rate in small muscle samples |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |